CepTor receives $20 million equity line from Fusion Capital

By Sheri Kasprzak

New York, Oct. 10 - CepTor Corp., Inc. said it has secured a standby equity distribution agreement for up to $20 million.

Under the terms of the agreement, Fusion Capital Fund II, LLC will buy shares of CepTor, but the details of the offering could not be determined by press time Monday.

Based in Hunt Valley, Md., CepTor is a biopharmaceutical company focused on treatments for neuromuscular and neurodegenerative diseases like muscular dystrophy and multiple sclerosis.

CepTor's stock closed unchanged Monday at $1.70.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.